Study ID | Country | Type of patients | Age | Sex | Randomization | PTFT | Rx Mode | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Male | Female | |||||||||||||||||
Pape, 1993 [35] | Haiti | PLWHIV | 12H | Placebo | 27 | 91 | 12H | Placebo | 2 years | N/A | ||||||||
Mean 31.1 years | Mean 30.6 years | 58 | 60 | |||||||||||||||
Cowie, 1996 [36] | Canada | Silicosis | RHZ | Placebo | 382 | 0 | 3RHZ | Placebo | 4 years | DOT | ||||||||
Mean 47.0 years | Mean 47.3 years | 191 | 191 | |||||||||||||||
Gordin, 1997 [37] | USA | PLWHIV | 6H | Placebo | 322 | 195 | 6H | Placebo | 2 ½ years | N/A | ||||||||
Mean 37.4 years | Mean 38.2 years | 260 | 257 | |||||||||||||||
Hawken, 1997 [11] | Kenya | PLWHIV | 6H | Placebo | 269 | 415 | 6H | Placebo | 2 years | Self administered | ||||||||
Mean 31.1 years | Mean 31.1 years | 342 | 342 | |||||||||||||||
Whalen, 1997 [38] | Uganda | PLWHIV | 6H | 3RH | 3RHZ | Placebo | 854 | 1882 | 6H | 3RH | 3RHZ | Placebo | 2 ½ years | Self administered | ||||
Mean 29 years | Mean 29 years | Mean 29 years | Mean 30 years | 931 | 556 | 462 | 787 | |||||||||||
Mean 31 years | Mean 31 years | 370 | 380 | |||||||||||||||
Alfaro, 2000 [39] | Spain | PLWHIV | 12H | 3RH | 102 | 31 | 12H | 3RH | 2 years | Self administered | ||||||||
Mean 32.2 years | Mean 32.2 years | 64 | 69 | |||||||||||||||
Fitzgerald, 2000 [40] | Haiti | PLWHIV | 6H | Placebo | 111 | 116 | 6H | Placebo | 2 years | Self administered | ||||||||
Mean 32 years | Mean 31.5 years | 119 | 114 | |||||||||||||||
HKCS, 2001 [41] | China | Silicosis | 6H | 3RH | 3R | Placebo | N/A | N/A | 6H | 3RH | 3R | Placebo | 2–5 years | Self administered | ||||
N/A | N/A | N/A | N/A | 173 | 167 | 172 | 167 | |||||||||||
Johnson, 2001 [15] | Uganda | PLWHIV | 6H | 3RH | 3RHZ | Placebo | N/A | N/A | 6H | 3RH | 3RHZ | Placebo | 5 years | Self administered | ||||
N/A | N/A | N/A | N/A | 931 | 556 | 462 | 787 | |||||||||||
Quigley, 2001 [42] | Zambia | PLWHIV | 9H | 3RZ | Placebo | 47 | 53 | 9H | 3RZ | Placebo | 3–7 years | Self administered | ||||||
N/A | N/A | N/A | 26 | 46 | 28 | |||||||||||||
N/A | N/A | |||||||||||||||||
Menzies, 2004 [43] | Canada | Households contacts | 4R | 9H | 55 | 51 | 4R | 9H | 2 years | Self administered | ||||||||
Mean 32.9 years | Mean 34.8 years | 58 | 58 | |||||||||||||||
Mean 37.7 years | Mean 37.0 years | 206 | 193 | |||||||||||||||
Zar, 2006 [44] | South Africa | PLWHIV | 6H | Placebo | 145 | 118 | 6H | Placebo | 2 years | N/A | ||||||||
Median 29.6 months | Median 22.1 months | 132 | 131 | |||||||||||||||
Geijo, 2007 [45] | Spain | Households contacts and evidence radiological of previous tuberculosis | 6H | 3RH | 53 | 43 | 6H | 3RH | 5 years | N/A | ||||||||
Median 44.16 years | Median 41.38 years | 45 | 51 | |||||||||||||||
Mohammed, 2007 [46] | South Africa | PLWHIV | 12H | Placebo | 58 | 60 | 12H | Placebo | 2 years | Patient nominated suppervisor | ||||||||
Mean 39.7 years | Mean 37.8 years | 68 | 50 | |||||||||||||||
Rivero, 2007 [47] | Spain | PLWHIV | 6H | 3RH | 2RZ | 251 | 61 | 6H | 3RH | 2RZ | 2 years | self administered | ||||||
Median 31.3 years | Median 33.0 years | Median 33.0 years | 108 | 103 | 105 | |||||||||||||
Spyridis, 2007 [48] | Greek | Households contacts and evidence radiological of previous tuberculosis | 4RH | 3RH | 9H | 476 | 450 | 4RH | 3RH | 9H | ≧ 3 years | self administered | ||||||
Mean 9.1 years | Mean 8.8 years | Mean 7.9 years | 474 | 220 | 232 | |||||||||||||
Menzies, 2008 [20] | Canada, Saudi Arabia, and Brazil | Households contacts | 4R | 9H | 446 | 400 | 4R | 9H | 1 year | N/A | ||||||||
N/A | N/A | 420 | 427 | |||||||||||||||
Trajman, 2009 [49] | Canada, Brazil, and Saudi Arabia | Households contacts | Median 33 years | N/A | N/A | 4R | 9H | 4 months | self administered | |||||||||
420 | 427 | |||||||||||||||||
Madhi, 2011 [50] | South Africa | PLWHIV and HIV exposed children | 24H | Placebo | 648 | 705 | 24H | Placebo | 2 years | N/A | ||||||||
Median 96.5 weeks | Median 95.5 weeks | 676 | 677 | |||||||||||||||
Martinson, 2011[51] | South Africa | PLWHIV | 3HP | 3RH | 72H | 6H | 192 | 956 | 3HP | 3RH | 72H | 6H | ≦ 6 years | DOT & self administered | ||||
Median 30.3 years | Median 30.5 years | Median 30.2 years | Median 30.4 years | 329 | 329 | 164 | 328 | |||||||||||
Sterling, 2011 [21] | USA, Canada, Brazil, and Spain | Households contacts and evidence radiological of previous tuberculosis | 3HP | 9H | 4214 | 3517 | 3HP | 9H | 33 months | self administered | ||||||||
Mean 36 | Mean 35 | 3986 | 3745 | |||||||||||||||
Chan, 2012 [52] | Taiwan | Prison inmates | 6H | 4R | 373 | 0 | 6H | 4R | 2 months | DOT | ||||||||
N/A | N/A | 183 | 190 | |||||||||||||||
Fuentes, 2012 [19] | Spain | Immigrant population | 6H | 3RH | 400 | 190 | 6H | 3RH | 5 years | self administered | ||||||||
Mean 26.1 years | Mean 26.1 years | 294 | 296 | |||||||||||||||
Swaminathan, 2012 [53] | India | PLWHIV | 6EH | 36H | 263 | 420 | 6EH | 36H | 3.5 years | self administered | ||||||||
Mean 29.9 years | Mean 30.2 years | 344 | 339 | |||||||||||||||
White, 2012 [54] | USA | Prison inmates | 4R | 9H | 339 | 25 | 4R | 9H | N/A | DOT | ||||||||
N/A | N/A | 180 | 184 | |||||||||||||||
Gray, 2013 [55] | South Africa | PLWHIV | 6H | Placebo | 83 | 84 | 6H | Placebo | 6.6 years | self administered | ||||||||
85 | 82 | |||||||||||||||||
Median 32 months | Median 38 months | |||||||||||||||||
Villarino, 2015 [22] | USA, Canada, Brazil, Hong Kong (China), and Spain | Children with recent household contact | 3HP | 9H | 538 | 520 | 3HP | 9H | 33 months | DOT | ||||||||
Median 10 years | Median 12 Years | 552 | 506 | |||||||||||||||
Sterling, 2014 [24] | USA, Brazil, Spain, Peru, Canada, and Hong Kong | Households contacts and evidence radiological of previous tuberculosis | 3HP | 9H | N/A | N/A | 3HP | 9H | 1 month | DOT | ||||||||
N/A | N/A | 3893 | 3659 | |||||||||||||||
Moro, 2016 [23] | USA and Brazil | Households contacts and evidence radiological of previous tuberculosis | N/A | N/A | 3352 | 2563 | 3HP | 9H | 3 months | DOT | ||||||||
3230 | 3002 | |||||||||||||||||
Sterling, 2016 [25] | United States, Brazil, Spain, Peru, Canada, and Hong Kong | PLWHIV | 3HP | 9H | 277 | 122 | 3HP | 9H | 6 years | DOT and self administered | ||||||||
Median 36 years | Median 36 years | 206 | 193 | |||||||||||||||
Gao, 2018 [16] | China | Older people | Range 50–70 years | 2054 | 1684 | 3HP | 2HP TW | Placebo | 2 years | DOT | ||||||||
1284 | 1299 | 1155 | ||||||||||||||||
Moro, 2018[56] | USA, Canada, Spain, Peru, and Brazil | Pregnant women | 9H | 3HP | 87 | 9H | 3HP | 33 months | DOT and self administered | |||||||||
Median 25 years | Median 23 Years | 56 | 31 | |||||||||||||||
Sun, 2018 [57] | Taiwan | Households contacts | 3HP | 9H | 152 | 111 | 3HP | 9H | 2 years | DOT | ||||||||
Mean 31.7 years | Mean 32 years | 132 | 131 | |||||||||||||||
Swindells, 2019 [26] | Africa, Asia, South America, North America, and the Caribbean | PLWHIV | 1HP | 9H | 1386 | 1614 | 1HP | 9H | ||||||||||
Median 35 years | Median 35 years | 1496 | 1504 | 4.5 years | Self administered | |||||||||||||
Ruan, 2020 [12] | China | Silicosis | Placebo | 3HP | N/A | N/A | Placebo | 3HP | 37 months | DOT | ||||||||
Median 57 years | Median 57 years | 259 | 254 | |||||||||||||||
Surey, 2021 [58] | United Kingdom | Households contacts | 3HP | 3RH | 26 | 26 | 3HP | 3RH | 2 months | Self administered | ||||||||
Mean 38.2 years | Mean 32.5 years | 27 | 25 |